STAT
OCTOBER 4, 2024
Italian pharma company Recordati said it will buy from Sanofi the global rights to an approved drug to treat cold agglutinin disease , a rare autoimmune disorder, for $825 million, Reuters reports. The Medicare Advantage market is expected to grow in 2025, despite big changes from insurers , STAT reports.
pharmaphorum
AUGUST 18, 2020
While both companies operate in virtual care and chronic condition management, their approaches are very different. Its second-quarter revenue leaped 125% to almost $92 million.
Ramblings of a pharmacist
APRIL 23, 2023
It’s a very useful metric for chronic diabetes management, because since red blood cells stick around in the blood for ~3 months, it can give you a sense of how well controlled a person’s diabetes is over the past three months, even if their current blood sugar is perfectly normal. They do… to a point.
Expert insights. Personalized for you.
254 
Let's personalize your content